Hohl Benjamin

Enliven Therapeutics, Inc. · CHIEF FINANCIAL OFFICER

Hohl Benjamin is listed in public filings as officer: CHIEF FINANCIAL OFFICER. This Hohl Benjamin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN). Investors use Hohl Benjamin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Enliven Therapeutics, Inc.ELVN$66k3.3k sharesSellSep 29, 2025$20.40--
Enliven Therapeutics, Inc.ELVN$67k3.3k sharesSellAug 27, 2025$20.63--
Enliven Therapeutics, Inc.ELVN$1.4k65 sharesSellJul 28, 2025$21.30--
Enliven Therapeutics, Inc.ELVN$65k3.2k sharesSellJul 28, 2025$20.45--
Enliven Therapeutics, Inc.ELVN$23k1k sharesSellJul 10, 2025$22.66--
Enliven Therapeutics, Inc.ELVN$4.3k198 sharesSellJun 27, 2025$21.66--
Enliven Therapeutics, Inc.ELVN$64k3.1k sharesSellJun 27, 2025$20.86--
Enliven Therapeutics, Inc.ELVN$68k3k sharesSellJun 13, 2025$22.55--
Enliven Therapeutics, Inc.ELVN$53k3.3k sharesSellMay 27, 2025$16.18--
Enliven Therapeutics, Inc.ELVN$1.3k69 sharesSellApr 28, 2025$19.12--
Enliven Therapeutics, Inc.ELVN$59k3.2k sharesSellApr 28, 2025$18.68--
Enliven Therapeutics, Inc.ELVN$69k3.3k sharesSellMar 27, 2025$21.33--
Enliven Therapeutics, Inc.ELVN$23k1k sharesSellMar 24, 2025$22.50--
Enliven Therapeutics, Inc.ELVN$66k3.3k sharesSellFeb 27, 2025$20.41--
Enliven Therapeutics, Inc.ELVN$23k1k sharesSellFeb 5, 2025$22.52--
Enliven Therapeutics, Inc.ELVN$70k3.3k sharesSellJan 27, 2025$21.59--
Enliven Therapeutics, Inc.ELVN$25k1k sharesSellJan 3, 2025$25.04--
Enliven Therapeutics, Inc.ELVN$20k900 sharesSellDec 30, 2024$22.51--
Enliven Therapeutics, Inc.ELVN$74k3.4k sharesSellDec 27, 2024$22.15--
Enliven Therapeutics, Inc.ELVN$105k4.3k sharesSellNov 27, 2024$24.78--
Enliven Therapeutics, Inc.ELVN$25k1k sharesSellNov 27, 2024$25.38--
Enliven Therapeutics, Inc.ELVN$160k5.6k sharesSellOct 28, 2024$28.49--
Enliven Therapeutics, Inc.ELVN$19k650 sharesSellOct 28, 2024$29.11--
Enliven Therapeutics, Inc.ELVN$24k814 sharesSellOct 18, 2024$30.00--
Enliven Therapeutics, Inc.ELVN$35k1.3k sharesSellOct 7, 2024$27.51--
Enliven Therapeutics, Inc.ELVN$281k10.2k sharesSellOct 4, 2024$27.51--
Enliven Therapeutics, Inc.ELVN$14k521 sharesSellOct 1, 2024$27.54--
Enliven Therapeutics, Inc.ELVN$51k2k sharesSellSep 30, 2024$25.33--
Enliven Therapeutics, Inc.ELVN$103k4.3k sharesSellSep 27, 2024$24.27--
Enliven Therapeutics, Inc.ELVN$96k4.3k sharesSellAug 27, 2024$22.54--
Enliven Therapeutics, Inc.ELVN$27k991 sharesSellJul 31, 2024$27.53--
Enliven Therapeutics, Inc.ELVN$1.7k61 sharesSellJul 29, 2024$27.44--
Enliven Therapeutics, Inc.ELVN$138k5.2k sharesSellJul 29, 2024$26.67--
Enliven Therapeutics, Inc.ELVN$75k3k sharesSellJul 12, 2024$25.07--
Enliven Therapeutics, Inc.ELVN$41k1.8k sharesSellJun 27, 2024$22.58--
Enliven Therapeutics, Inc.ELVN$28k1.3k sharesSellJun 27, 2024$21.79--
Enliven Therapeutics, Inc.ELVN$27k1.1k sharesSellJun 27, 2024$23.43--
Hohl Benjamin History Trades | TradingNote